<DOC>
	<DOCNO>NCT01595503</DOCNO>
	<brief_summary>Repetitive transcranial magnetic stimulation ( rTMS ) new noninvasive therapy use magnetic energy apply scalp modulate activity underlie region brain . In study examine efficacy treat auditory hallucination schizophrenia rTMS , compare two method target stimulation language processing region brain . One method target stimulation site use scalp landmark , use functional magnetic resonance imaging ( fMRI ) combine language task .</brief_summary>
	<brief_title>Transcranial Magnetic Stimulation Treatment Auditory Hallucinations Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Hallucinations</mesh_term>
	<criteria>Provide sign date informed consent form Male female , age 18 60 Willing comply study procedure available duration study Primary diagnosis schizophrenia schizoaffective disorder accord DSMIV ( 29 ) Currently report AHs , rat minimum 4 ( moderate ) auditory hallucination item Brief Psychiatric Rating Scale ( BPRS ; 27 ) , AH present daily AHs must fail resolve minimum two adequate trial ( dos within standard therapeutic range minimum 8 week ) psychotropic medication include least one atypical antipsychotic medication ; document trial antipsychotic medication limit intolerable side effect , e. g. extrapyramidal symptom , tardive dyskinesia , weight gain , neurolepticinduced dysphoria , also consider equivalent adequate trial . Weight girth compatible bore MRI scanner ; generally men 6 foot tall &lt; 250 lb , men 6 foot tall &lt; 220 lb , woman 5'11 '' tall &lt; 220 lb , woman 5'10 '' tall &lt; 200 lbs Substance abuse dependence past 1 month Current past history serious medical neurological illness could compromise brain function present increase risk seizure , e. g. condition may significantly alter electrolyte balance , stroke , epilepsy , history seizure ; Pregnant try become pregnant ; Inability tolerate small , enclosed space without anxiety ; Metals , implant metallic substance within body might cause adverse effect subject strong magnetic field , interfere image acquisition , e. g. aneurysm clip , retain particle , neurostimulators , foilbacked transdermal patch ; Facial tattoo metallic ink Inability follow study protocol Change antipsychotic therapy previous 2 week Currently alternative treatment order Unstable symptom could , judgment study team , exhibit symptomatic worsen course protocol Current treatment another investigational drug intervention Anything , opinion investigator , would place subject increase risk preclude subject 's full compliance completion study ; No quantifiable motor threshold TMS dosage accurately determine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Schizophrenia , auditory hallucination</keyword>
</DOC>